ImmunityBio, Inc.IBRXNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank83
5Y CAGR+44.1%
Year-over-Year Change
Year-over-year gross profit growth rate
5Y CAGR
+44.1%/yr
Long-term compound
Percentile
P83
Within normal range
vs 5Y Ago
6.2x
Strong expansion
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 663.21% |
| 2024 | 2270.58% |
| 2023 | 159.17% |
| 2022 | -74.30% |
| 2021 | 54.38% |
| 2020 | 106.75% |
| 2019 | -384.10% |
| 2018 | 6915.56% |
| 2017 | 2.27% |
| 2016 | -81.36% |